Movement Disorders (revue) - Curation (Ncbi)

Index « Keywords » - entrée « Patient Satisfaction »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Patient Readmission (economics) < Patient Satisfaction < Patient Satisfaction (statistics & numerical data)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 14.
Ident.Authors (with country if any)Title
000204 (2000) A. Brashear [États-Unis] ; K. Bergan ; J. Wojcieszek ; E R Siemers ; W. AmbrosiusPatients' perception of stopping or continuing treatment of cervical dystonia with botulinum toxin type A.
000942 (2002) G-Y R. Hsiung [Canada] ; S K Das ; R. Ranawaya ; A-L Lafontaine ; O. SuchowerskyLong-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period.
000C04 (2003) Amy N. Hill [États-Unis] ; Joseph Jankovic [États-Unis] ; Kevin D A T. Vuong ; Don DonovanTreatment of hypophonia with collagen vocal cord augmentation in patients with parkinsonism.
001152 (2005) Katherine A. Grosset [Royaume-Uni] ; Donald G. GrossetPatient-perceived involvement and satisfaction in Parkinson's disease: effect on therapy decisions and quality of life.
001177 (2005) Daniel Truong [États-Unis] ; Drake D. Duane ; Joseph Jankovic [États-Unis] ; Carlos Singer ; Lauren C. Seeberger ; Cynthia L. Comella ; Mark F. Lew ; Robert L. Rodnitzky ; Fabio O. Danisi ; James P. Sutton ; P David Charles ; Robert A. Hauser ; Geoffrey L. SheeanEfficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study.
001423 (2006) Kelly L. Sullivan [États-Unis] ; Joseph F. Staffetti ; Robert A. Hauser ; Peter B. Dunne ; Theresa A. ZesiewiczTegaserod (Zelnorm) for the treatment of constipation in Parkinson's disease.
001716 (2006) Claudia Trenkwalder [Allemagne] ; Karin Stiasny-Kolster ; Andreas Kupsch ; Wolfgang H. Oertel ; Juergen Koester ; Juergen ReessControlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome.
001740 (2006) Michela Barichella [Italie] ; Agnieszka Marczewska ; Roberta De Notaris ; Antonella Vairo ; Cinzia Baldo ; Andrea Mauri ; Chiara Savardi ; Gianni PezzoliSpecial low-protein foods ameliorate postprandial off in patients with advanced Parkinson's disease.
002824 (2009) Kelly E. Lyons [États-Unis] ; Rajesh PahwaAn open-label conversion study of pramipexole to ropinirole prolonged release in Parkinson's disease.
002B84 (2010) E Ray Dorsey [États-Unis] ; Lisa M. Deuel ; Tiffini S. Voss ; Kara Finnigan ; Benjamin P. George ; Sheelah Eason ; David Miller ; Jason I. Reminick ; Anna Appler ; Joyce Polanowicz ; Lucy Viti ; Sandy Smith ; Anthony Joseph ; Kevin M. BiglanIncreasing access to specialty care: a pilot, randomized controlled trial of telemedicine for Parkinson's disease.
002D60 (2010) Robert A. Hauser [États-Unis] ; Anthony H V. Schapira ; Olivier Rascol ; Paolo Barone ; Yoshikuni Mizuno ; Laurence Salin ; Monika Haaksma ; Nolwenn Juhel ; Werner Poewe [Autriche]Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease.
002E53 (2010) E Ray Dorsey [États-Unis] ; Tiffini S. Voss ; David R. Shprecher ; Lisa M. Deuel ; Christopher A. Beck ; Irenita F. Gardiner ; Margaret A. Coles ; Richard S. Burns ; Frederick J. Marshall ; Kevin M. BiglanA U.S. survey of patients with Parkinson's disease: satisfaction with medical care and support groups.
002F23 (2011) Anne Marthe Meppelink [Pays-Bas] ; Rickard Nyman ; Teus Van Laar ; Martje Drent ; Ted Prins ; Klaus Leonhard LeendersTranscutaneous port for continuous duodenal levodopa/carbidopa administration in Parkinson's disease.
003506 (2011) Christine Daniels [Allemagne] ; Paul Krack ; Jens Volkmann ; Jan Raethjen ; Markus O. Pinsker ; Manja Kloss ; Volker Tronnier ; Alfons Schnitzler ; Lars Wojtecki ; Kai Bötzel ; Adrian Danek ; Rüdiger Hilker ; Volker Sturm ; Andreas Kupsch ; Elfriede Karner ; Günther Deuschl ; Karsten WittIs improvement in the quality of life after subthalamic nucleus stimulation in Parkinson's disease predictable?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Patient Satisfaction" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Patient Satisfaction" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Patient Satisfaction
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024